| Product Number | Description |
|---|
| 00/410 |
MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
|
| 00/416 |
Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
|
| 00/418 |
MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
|
| 00/422 |
High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
|
| 00/464 |
Streptokinase (3rd International Standard 2001)
|
| 00/562 |
Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
|
| 00/572 |
Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
|
| 007SP |
Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
|
| 01/420 |
Interleukin-17 (Human rDNA derived)(International Reference Reagent)
|
| 01/528 |
Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]
(Panel of 5 ampoules)
|
| 01/530 |
Oral Poliovaccine Sabin Type 2 reference strain
(Panel of 5 ampoules)
|
| 01/532 |
Oral Poliovaccine Sabin Type 3 reference strain
(Panel of 5 ampoules)
|
| 01/572 |
Anti-D Immunoglobulin(2nd International Standard)
|
| 01/580 |
Thrombin, human(2nd International Standard)
|
| 01/600 |
Anti-Toxoplasma IgG, Human(International Standard)
|
| 01/602 |
Anti-Parvovirus B19, plasma, human(2nd International Standard)
|
| 02/168 |
Prekallikrein Activator (PKA), Human(2nd International Standard)
|
| 02/186 |
Anti-Dengue Virus Types 1+2+3+4, Human (International Reference Reagent)
|
| 02/206 |
Factor XIII Plasma, Human (1st International Standard)
|
| 02/210 |
HIV (antibody), 1st International Reference Panel
|
| 02/226 |
IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
|
| 02/228 |
IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
|
| 02/254 |
Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)
|
| 02/286 |
Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
|
| 02/306 |
Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)
|
| 02/342 |
Protein C Plasma, Human(2nd International Standard)
|
| 03/116 |
Blood Coagulation Factor V, Plasma Human (1st International Standard)
|
| 03/148 |
Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
|
| 03/150 |
Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
|
| 03/152 |
Anti-HPA-1a (International Standard)
|
| 03/164 |
Anti-B minimum potency reference preparation(International Standard)
|
| 03/178 |
Vitamin B12, Serum Folate and holoTC (International standard)
|
| 03/188 |
Anti-A minimum potency reference preparation(International Standard)
|
| 03/190 |
Anti-HPA-3a(minimum potency)(International Reference Reagent)
|
| 03/192 |
Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
|
| 03/200 |
Interleukin - 18 (Human rDNA derived)(International Reference Reagent)
|
| 03/228 |
Protein S, Plasma, Human(2nd International Standard)
|
| 03/262 |
Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
|
| 04/150 |
Tetanus Toxoid For Flocculation Test(2nd International Standard)
|
| 04/166 |
TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
|
| 04/176 |
Plasmodium falciparum DNA for NAT Assays(1st International Standard)
|
| 04/224 |
Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
|
| 04/252 |
Protein C Concentrate, Human(1st International Standard)
|
| 05/106 |
Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
|
| 05/112 |
Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
|
| 05/122 |
Syphilitic plasma IgG (human)(1st International Standard)
|
| 05/130 |
Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
|
| 05/134 |
Anti-human papillomavirus type 16 serum (1st International Standard)
|
| 05/162 |
Alpha-1-Antitrypsin, plasma derived(1st International standard)
|
| 06/124 |
Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
|
| 06/128 |
Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
|
| 06/140 |
Pertussis Antiserum(human)1st IS-WHO international Standard.
|
| 06/142 |
Pertussis Antiserum (Human) 1st WHO Reference Reagent
|
| 06/166 |
Antithrombin Concentrate, Human (3rd International Standard)
|
| 06/202 |
Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
|
| 06/206 |
Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
|
| 07/150 |
Human Plasma Anti-Influenza H5N1 (1st International Standard)
|
| 07/164 |
Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
|
| 07/202 |
Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
|
| 07/216 |
Diphtheria Toxoid (Adsorbed) (4th International Standard)
|
| 07/222 |
RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
|
| 07/228 |
Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
|
| 07/270 |
BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
|
| 07/272 |
BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
|
| 07/274 |
BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
|
| 07/306 |
Anti-A and anti-B in IVIG: Positive control for haemagglutination tests
(International Reference Reagent)
|
| 07/308 |
Anti-A and anti-B in IVIG Negative control
for haemagglutination tests (International Reference Reagent)
|
| 07/310 |
Anti-A and anti-B in IVIG: Limit reference preparation(International Reference Reagent)
|
| 07/316 |
Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
|
| 07/328 |
Unfractionated Heparin (6th I.S.)
|
| 07/350 |
Blood Coagulation Factor VIII Concentrate (8th I.S.)
|
| 07/364 |
Chorionic Gonadotrophin, (5th IS)
|
| 08/150 |
HIV-2 RNA(1st International Standard)
|
| 08/158 |
Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
|
| 08/160 |
Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
|
| 08/204 |
Thyroid Stimulating Antibody (2nd I.S.)
|
| 08/214 |
Meningococcal Serogroup C polysaccharide (1st International Standard)
|
| 08/218 |
Tetanus Toxoid Adsorbed (4th International Standard)
|
| 08/230 |
Streptodornase (2nd International Standard)
|
| 08/256 |
C1- Inhibitor, Concentrate (1st International Standard)
|
| 08/258 |
Antithrombin, Plasma (3rd International Standard)
|
| 08/262 |
C1 Inhibitor (Plasma)(1st International Standard)
|
| 08/266 |
Sex Hormone Binding Globulin.(2nd International Standard)
|
| 08/270 |
Anti-A and Anti-B in IVIG: Positive and Negative control panel(1st International Reference Reagent)
(2 ampoules of 07/306 and 2 ampoules of 07/308)
|
| 08/282 |
Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
|
| 09/110 |
Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
|
| 09/136 |
Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
|
| 09/138 |
Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR
(1st I.S.)
|
| 09/140 |
Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
|
| 09/154 |
Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)
|
| 09/162 |
Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
|
| 09/172 |
Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
|
| 09/182 |
VWF Factor Concentrate (2nd International Standard)
|
| 09/186 |
Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
|
| 09/188 |
Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
|
| 09/234 |
Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
|
| 09/242 |
Fibrinogen Concentrate (B)(2nd International Standard)
|
| 09/260 |
Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
|
| 09/264 |
Fibrinogen Plasma (D)(3rd International Standard)
|
| 09/284 |
Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
|
| 09/296 |
Pro-Insulin, human (1st International Standard)
|
| 10/140 |
Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
|
| 10/164 |
Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].
|
| 10/166 |
Oral Poliovaccine Sabin Type 2 reference
|
| 10/168 |
Oral Poliovaccine Sabin Type 3 reference
|
| 10/176 |
Interleukin-29 (Interferon Lamda 1)
|
| 10/178 |
Endotoxin (3rd International Standard)
|
| 10/198 |
Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)
|
| 10/202 |
Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
|
| 10/232 |
Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
|
| 10/234 |
Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
|
| 10/236 |
Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
|
| 10/238 |
Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
|
| 10/242 |
Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
|
| 10/252 |
Factor VII Concentrate(2nd International Standard)
|
| 10/262 |
Diphtheria Antitoxin Human IgG(1st International Standard)
|
| 10/266 |
4th WHO International Standard for HBV DNA for NAT
|
| 10/272 |
BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
|
| 10/286 |
Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
|
| 11/126 |
Factors II and X Concentrate (4th International standard)
|
| 11/170 |
Erythropoietin, recombinant, for Bioassay (3rd International Standard)
|
| 11/176 |
(3rd International Standard) Low Molecular Weight Heparin
|
| 11/184 |
High Molecular Weight Urokinase(2nd International Standard)
|
| 11/214 |
Blood Group Genotyping Reference Panel ((International Reference Reagent)
|
| 11/216 |
Chagas Antibody Reference Panel ( 1st International Standard)
|
| 11/234 |
Immunoglobulin E(IgE) human serum (3rd International Standard)
|
| 11/236 |
Factor XIa (1st International Reference Reagent)
|
| 12/104 |
International Standard for IPV 12/104 (3rd International Standard)
|
| 12/154 |
Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
|
| 12/188 |
Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived)
(International Standard)
|
| 12/208 |
Parvovirus B19 (3rd International Standard)
|
| 12/224 |
HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
|
| 12/226 |
HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
|
| 12/244 |
Vi polysaccharide of C freundii WHO 1st International Standard
|
| 12/252 |
ADAMTS 13 Plasma (1st International Standard)
|
| 12/306 |
Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
|
| 13/100 |
Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
|
| 13/122 |
Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)
|
| 13/132 |
Antibodies, Human, to Toxoplasma gondii (4th International Standard).
|
| 13/146 |
C-Peptide, Human (1st International Standard).
|
| 13/172 |
Lupus Anticoagulant (1st International Reference Panel)
|
| 13/204 |
TNF Rec II- FC Fusion protein (1st International Standard)
|
| 13/206 |
Plasmin (4th International Standard)
|
| 13/212 |
Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
|
| 13/214 |
HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
|
| 13/238 |
Anti-EV71 serum LOW (WHO International Reference Reagent)
|
| 13/246 |
Meningococcal serogroup A polysaccharide (1st WHO International Standard).
|
| 14/114 |
JC Virus (JCV) DNA (1st International Standard)
|
| 14/140 |
1st International Standard for Anti EV71 Serum Human
|
| 14/148 |
Human Blood Factor IX Concentrate (5th International Standard).
|
| 14/150 |
Hepatitis C virus (HCV) For nucleic acid
amplification techniques (5th International standard 2015)
|
| 14/156 |
Meningococcal group X polysaccharide (1st WHO International Standard)
|
| 14/210 |
Biological activities of Rituximab WHO 1st International Standard
|
| 14/212 |
BK Virus (BKV)(1st International Standard)
|
| 14/300 |
High titre anti-A and anti-B in serum (WHO Reference Reagent).
|
| 14/316 |
Factor IX activated (FIXa) 2nd WHO International Standard
|
| 15/102 |
Activated Blood Coagulation Factor X (FXa), Human
|
| 15/106 |
Ancrod
|
| 15/126 |
Bordetella pertussis toxin (20µg). (2nd International Standard)
|
| 15/136 |
EBOV RNA NP-VP35-GP in-run control
|
| 15/138 |
EBOV RNA VP40-L in-run control
|
| 15/174 |
Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent
|
| 15/180 |
Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)
|
| 15/220 |
Anti-EBOV plasma, human (WHO Reference Reagent)
|
| 15/222 |
EBOV RNA NP-VP35-GP (WHO Reference Reagent)
|
| 15/224 |
EBOV RNA VP40-L (WHO Reference Reagent)
|
| 15/240 |
Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)
|
| 15/242 |
Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)
|
| 15/262 |
Anti- EBOV Convalescent Plasma Pool - Sierra Leone (International Reference Reagent)
|
| 15/266 |
HHV-6 Virus 1st WHO International Standard
|
| 15/304 |
Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard
|
| 16/120 |
WHO 1st International Reference Panel for Genomic JAK2 V617F
|
| 16/126 |
Native Vi polysaccharide (S. Typhi)
|
| 16/138 |
Anti-Typhoid capsular Vi polysaccharide IgG (Human) 1st WHO International Standard
|
| 16/166 |
Diphtheria Antitoxin Equine DI.
|
| 16/170 |
Infliximab(1st International Standard)
|
| 16/194 |
HIV-1 RNA (4th International Standard)
|
| 16/250 |
1st International Reference Panel for genomic KRAS codons 12 and 13 mutations
|
| 16/284 |
Antiserum to Respiratory Syncytial Virus WHO 1st International Standard
|
| 16/344 |
WHO Anti-EBOV Convalescent Plasma (International Reference Panel)
|
| 16/376 |
Plasmodium falciparum antigens (1st International Standard)
|
| 2BADS |
Anti-Brucella Abortus Serum, Bovine (International Standard)
|
| 2CPBETAAT |
Clostridium Perfringens Beta Antitoxin (2nd International Standard)
|
| 2CPEPAT |
Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)
|
| 59/016 |
Corticotrophin (ACTH), Porcine (3rd International Standard)
|
| 61/001 |
Botulinum Antitoxin Equine Type D (1st International Standard)
|
| 62/001 |
Serum Gonadotrophin, Equine (2nd International Standard)
|
| 65/093 |
Anti-Thyroglobulin Serum, Human (International Reference reagent)
|
| 67/086 |
Immunoglobulins G, A, M Serum Human (International Standard)
|
| 68/356 |
Renin, Human (International Standard)
|
| 69/194 |
Glucagon, Porcine (First International Standard)
|
| 73/545 |
Placental Lactogen, Human (International Reference Preparation)
|
| 73/601 |
Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
|
| 74/586 |
Corticotrophin (ACTH), Porcine (International Working Standard)
|
| 75/551 |
Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)
|
| 75/569 |
Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)
|
| 76/522 |
Opacity 5IRP WHO International Standard
|
| 76/575 |
Oxytocin(4th International Standard)
|
| 77/512 |
Lysine Vasopressin(1st International Standard)
|
| 78/543 |
Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)
|
| 78/554 |
Luteinizing Hormone, Pituitary, alpha subunit (International Standard)
|
| 78/556 |
Luteinizing Hormone, Pituitary, beta subunit (International standard)
|
| 79/500 |
Parathyroid Hormone, Human (1st International Ref. Preparation)
|
| 80/505 |
Growth Hormone, Human, Pituitary. WHO International Standard
|
| 80/590 |
Tetracosactide. International Ref. Preparation
|
| 81/535 |
Luteinizing Hormone, Human, Pituitary (3rd International Standard)
|
| 81/565 |
Thyroid Stimulating Hormone, Human. WHO International Standard
|
| 82/518 |
Dermatophagoides Pteronyssinus Extract. WHO International Standard
|
| 82/520 |
Timothy Pollen Extract. WHO International Standard
|
| 82/585 |
Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)
|
| 82/632 |
Parathyroid Hormone, Bovine. WHO International Standard
|
| 83/500 |
Insulin, Human. WHO International Standard
|
| 83/501 |
Beta Thromboglobulin, Purified Human. WHO International Standard
|
| 83/505 |
Platelet Factor 4 Human, Purified. WHO International Standard
|
| 83/511 |
Insulin, Bovine. WHO International Standard
|
| 83/514 |
Interferon alpha-1D, (Human rDNA derived) WHO International Standard
|
| 83/515 |
Insulin, Porcine. WHO International Standard
|
| 83/573 |
Prolactin, Human (4th WHO International Standard.)
|
| 83/575 |
Follicle Stimulating Hormone, Pituitary. WHO International Standard
|
| 84/510 |
C- Peptide of Human Insulin
|
| 84/514 |
Proinsulin, Bovine. International Ref. Preparation
|
| 84/522 |
Birch Pollen Extract. WHO International Standard
|
| 84/528 |
Proinsulin, Porcine. International Ref. Reagent
|
| 84/581 |
Short Ragweed Pollen Extract. WHO International Standard
|
| 84/611 |
Proinsulin, Human
|
| 84/614 |
Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard
|
| 84/685 |
Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard
|
| 85/506 |
C-Reactive Protein, Human. WHO International Standard
|
| 85/616 |
Haemoglobin F Lysate, Raised. WHO Reference Reagent
|
| 85/669 |
Atrial Natriuretic Factor, Human. WHO International Standard
|
| 86/500 |
Interleukin- 2 (Human, rDNA derived)(2nd International Standard)
|
| 86/632 |
Interleukin-1 alpha (Human rDNA derived) WHO International Standard
|
| 86/680 |
Interleukin-1 beta (Human, rDNA derived) WHO International Standard
|
| 86/690 |
Inhibin, Porcine WHO International Standard
|
| 87/640 |
Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
|
| 88/556 |
Calcitonin, Eel WHO International Standard
|
| 88/638 |
Thyroxine-binding globulin. WHO International Standard
|
| 88/646 |
Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
|
| 88/656 |
Interleukin-4 (Human, rDNA derived) WHO International Standard
|
| 89/512 |
Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived)
WHO International Standard
|
| 89/520 |
Interleukin-8 (Human, rDNA derived) WHO International Standard
|
| 89/548 |
Interleukin-6 (Human, rDNA derived) WHO International Standard
|
| 89/620 |
Calcitonin, Human. WHO International Standard
|
| 89/666 |
Haemoglobin A2 Lysate, Raised. WHO Reference Reagent
|
| 90/530 |
Interleukin-7 (Human, rDNA derived) WHO Reference Reagent
|
| 90/534 |
Mumps Vaccine (Live) WHO Reference Reagent
|
| 90/586 |
Interleukin-5 (Human, rDNA derived) WHO Reference Reagent
|
| 90/636 |
HIV-1 P24 Antigen WHO International Standard
|
| 90/712 |
Basic Fibroblast Growth Factor (Human, rDNA derived)
WHO International Standard
|
| 91/510 |
Interleukin-3 (Human, rDNA derived) WHO International Standard
|
| 91/530 |
Epidermal Growth Factor (Human, rDNA derived)
WHO International Standard
|
| 91/550 |
Epidermal Growth Factor (1-52) (Human, rDNA derived)
WHO Reference Reagent
|
| 91/554 |
Insulin-like growth Factor 1 WHO International Standard
|
| 91/624 |
Inhibin A, Human, recombinant WHO International Standard
|
| 91/626 |
Activin A, Human, Recombinant. WHO Reference Reagent
|
| 91/678 |
Interleukin-9 (Human,rDNA derived) WHO Reference Reagent
|
| 91/682 |
Stem Cell Factor (Human rDNA derived) WHO Reference Reagent
|
| 91/688 |
Rubella Vaccine (Live) 1st International Reference Reagent
|
| 92/510 |
Follicle Stimulating Hormone, Human, recombinant. WHO International Standard
|
| 92/512 |
Follicle Stimulating Hormone, urofollitropin Human Urinary
WHO International Standard
|
| 92/648 |
Measles Vaccine (Live) 2nd International Reference Reagent
|
| 92/654 |
Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human
WHO International Standard
|
| 92/680 |
Serum amyloid A protein. WHO International Standard
|
| 92/788 |
Interleukin-11 (Human, rDNA derived) WHO Reference Reagent
|
| 93/556 |
Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent
|
| 93/562 |
Leukaemia Inhibitory Factor (Human, rDNA derived)
WHO Reference Reagent
|
| 93/564 |
Oncostatin M (Human, rDNA derived) WHO Reference Reagent
|
| 93/574 |
Bone morphogenetic Protein-2 (Human, rDNA derived)
WHO Reference Reagent
|
| 93/722 |
Interleukin-10 (Human rDNA derived) WHO Reference Reagent
|
| 94/532 |
Pertussis Vaccine (Whole Cell) WHO International Standard
|
| 94/572 |
Ferritin, Human, recombinant. WHO International Standard
|
| 94/622 |
Interleukin-13 (Human, rDNA derived) WHO Reference Reagent
|
| 94/674 |
Thyroid Stimulating Hormone, Human recombinant
WHO Reference Reagent
|
| 94/684 |
Ciliary Neurotrophic Factor (Human, rDNA derived)
WHO Reference Reagent
|
| 94/728 |
Platelet-derived Growth Factor-BB (Human, rDNA derived)
WHO International Standard
|
| 94/730 |
Tissue Plasminogen Activator (tPA) Antigen in Plasma
WHO International Standard
|
| 94/754 |
Interferon Omega (Human, rDNA derived) WHO International Standard
|
| 94/784 |
Interferon alpha (Human, leukocyte derived)WHO International Standard
|
| 94/786 |
Interferon alpha Concensus Sequence (Human rDNA derived)
WHO International Standard
|
| 94/790 |
MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard
|
| 95/522 |
Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard
|
| 95/528 |
Folate, Whole Blood Haemolysate WHO International Standard
|
| 95/542 |
MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C
WHO International Standard
|
| 95/544 |
Interleukin-12 (Human, rDNA derived) WHO Reference Reagent
|
| 95/554 |
Interleukin-15 (Human, rDNA derived) WHO Reference Reagent
|
| 95/566 |
Interferon alpha-2b (Human, rDNA derived) WHO International Standard
|
| 95/568 |
Interferon Alpha n1 (Human lymphoblastoid cell derived)
WHO International Standard
|
| 95/572 |
Interferon alpha-1/8 (Human, rDNA derived)
WHO International Standard
|
| 95/574 |
Interferon Alpha n3 (Human, leukocyte derived)
WHO International Standard
|
| 95/580 |
Interferon alpha-2c (Human, rDNA derived) WHO International Standard
|
| 95/584 |
Anti-hepatitis E Serum, Human WHO Reference Reagent
|
| 95/646 |
Parathyroid Hormone 1-84, human, recombinant (1st International Standard)
|
| 95/650 |
Interferon alpha-2a (Human, rDNA derived) WHO International Standard
|
| 96/532 |
FMS-like tyrosine kinase 3 ligand (Human, rDNA derived)
WHO Reference Reagent
|
| 96/534 |
Brain-derived Neurotrophic Factor (Human, rDNA derived)
WHO Reference Reagent
|
| 96/538 |
Insulin-like growth Factor-II (Human rDNA derived)
WHO Reference Reagent
|
| 96/556 |
Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard
|
| 96/564 |
Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived)
WHO Reference Reagent
|
| 96/572 |
MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent
|
| 96/578 |
MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent
|
| 96/602 |
Luteinizing Hormone, Human, recombinant WHO International Standard
|
| 96/666 |
Anti-Human Globulin International Reference Reagent
|
| 96/668 |
Prostate Specific Antigen (free) WHO International Standard
|
| 96/784 |
Inhibin B, Human WHO Reference Reagent
|
| 97/550 |
Islet Cell Antibodies WHO Reference Reagent
|
| 97/562 |
Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)
|
| 97/594 |
Leptin, Human, Recombinant WHO International Standard
|
| 97/626 |
Leptin, Mouse, Recombinant WHO International Standard
|
| 97/642 |
Bordetella pertussis anti serum (mouse) 1RR
|
| 97/646 |
Anti-Hepatitis A Immunoglobulin, Human (W1041)
WHO International Standard
|
| 97/648 |
Anti-Measles serum (3rd International Standard)
|
| 97/714 |
Prolactin, Human, recombinant. WHO Reference Reagent
|
| 97/756 |
MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent
|
| 97/758 |
MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G
WHO International Standard
|
| 98/524 |
MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G
WHO International Standard
|
| 98/574 |
Somatropin WHO International Standard
|
| 98/580 |
Prolactin Human, recombinant, glycosylated WHO Reference Reagent
|
| 98/582 |
Prolactin, Human, recombinant, non-glycosylated
WHO Reference Reagent
|
| 98/586 |
Calcitonin, Salmon. WHO International Standard
|
| 98/596 |
MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent
|
| 98/708 |
Haemiglobincyanide WHO International Standard
|
| 98/714 |
Tissue Plasminogen Activator, Human, Recombinant
WHO International Standard
|
| 99/616 |
Yellow Fever Vaccine. WHO International Standard
|
| 99/642 |
Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent
|
| 99/650 |
Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent
|
| 99/666 |
Anti-HPA-5b (Minimum Potency) WHO Reference Reagent
|
| 99/688 |
Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent
|
| 99/692 |
Chorionic Gonadotrophin, nicked beta subunit, Human
WHO Reference Reagent
|
| 99/708 |
Chorionic Gonadatrophin, beta core fragment, Human
WHO Reference Reagent
|
| 99/720 |
Chorionic Gonadotrophin, alpha subunit, Human (purified)
|
| 99/836 |
Anti-D Minimum Potency Standard for blood grouping reagents
WHO International Standard
|
| AFP |
Alpha-Foetoprotein. WHO International Standard
|
| B2M |
Beta-2 Microglobulin. WHO International Standard
|
| BUSB |
Botulinum Antitoxin Equine Type B. WHO International Standard
|
| CDS |
Anti-Canine Distemper Serum. WHO International Standard
|
| CHAN |
Cholera Antitoxin, Goat. WHO International Standard
|
| CHS |
Anti-Canine Hepatitis Serum
|
| COT |
Clostridium novyi (alpha) Toxoid. WHO Reference Reagent
|
| CWBETATD |
Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT
WHO Reference Reagent
|
| CWEPSILTD |
Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT
WHO Reference Reagent
|
| DY |
Anti-Dysentery (shiga) serum, Equine. WHO International Standard
|
| JNIH-3 |
Acellular Pertussis Vaccine - 1st IS.
|
| JNIH-5 |
Bordetella pertussis toxin (PT) 1st IS
|
| MGDS |
Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent
|
| NDS |
Anti-Newcastle Disease Serum. WHO International Standard
|
| NVIA |
Newcastle Disease Vaccine (Inactivated) WHO International Standard
|
| OE |
Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard
|
| PE |
Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine
WHO International Standard
|
| PPDA |
Purified Protein Derivative (PPD) of M Avium Tuberculin
WHO International Standard
|
| PPDBOV |
Purified Protein Derivative (PPD) of Bovine Tuberculin
WHO International Standard
|
| PPDT |
Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin
WHO International Standard
|
| QF |
Anti-Q Fever Serum, Bovine WHO International Standard
|
| RBT/16 |
Thromboplastin, Rabbit, Plain 5th International Standard 2016.
|
| RTF/16 |
Thromboplastin, Human, Recombinant, Plain 5th International Standard
2016.
|
| RUBI-1-94 |
Anti-rubella Immunoglobulin, Human WHO International Standard
|
| SES |
Swine Erysipelas Serum (anti-N) WHO Reference Reagent
|
| SFS |
Anti-Swine Fever Serum WHO International Standard
|
| SMV |
Smallpox Vaccine WHO International Standard
|
| SPDS-S2 |
Anti-Salmonella Pullorum Serum (Std. Form S)
WHO International Standard
|
| SPDS-V |
Anti-Salmonella Pullorum Serum (Variant Form V)
WHO International Standard
|
| SPLS |
Anti-Staphylococcal P-V Leucocidin serum, Equine
WHO Reference Reagent
|
| STA |
Staphylococcus Alpha Antitoxin, Equine WHO International Standard
|
| STT |
Diphtheria (Schick) Test Toxin WHO International Standard
|
| TILI |
Anti-tick borne encephalitis serum (Louping Ill)
WHO International Standard
|
| TISA |
Anti-tick borne encephalitis serum (Sophyn & Absettarov)
WHO International Standard
|
| TYVK |
Typhoid Vaccine (acetone-inactivated) WHO International Standard
|
| TYVL |
Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard
|
| VI |
Gas Gangrene Antitoxin (Cl. Septicum), Equine
WHO International Standard
|
| W1004 |
Anti-C complete blood typing serum,human WHO International Standard
|
| W1005 |
Anti-E complete blood typing serum, human WHO International Standard
|
| W1007 |
Anti-c Incomplete blood typing serum, human WHO International Standard
|
| W1044 |
Anti-Varicella zoster immunoglobulin WHO International Standard
|
| W1062 |
Anti smooth muscle(anti actin) autoantibody.
WHO Reference Reagent
|
| W1063 |
Anti nuclear ribonucleoprotein(nRNP) autoantibody
WHO Reference Reagent
|
| W1066 |
Rheumatoid Arthritis serum. WHO Reference Reagent
|
| YF |
Anti-Yellow Fever Serum, monkey WHO Reference Reagent
|